Home / Stocks / COR

Cencora (COR, Health Care Distributors) Stock Valuation & Fair Value Fairly valued

Cencora (COR, Health Care Distributors) trades at a blended P/E of 17.8, about 15% above its historical normal valuation, with a forward growth estimate of 10.8% and a PEG of 1.66. Analysts' one-year estimates have been hit 82% of the time.

DATA AS OF 2026-08-21
Blended P/E
17.8
Normal P/E
15.5
PEG
1.66
Fwd growth
10.8%
Div yield
0.8%
RSI (14)
54.5
Neutral

Valuation flags

Verdict history

tickerseer's rating has been fairly valued since 2026-06-03.

Price and rating by weekClose moved +19.0 percent from 2026-06-03 to 2026-08-17, with 0 rating changes over 21 recorded weeks.2026-06-03: Fairly valued, close 263.64 (recalculated)2026-06-10: Fairly valued, close 281.24 (recalculated)2026-06-14: Fairly valued, close 281.67 (recalculated)2026-06-16: Fairly valued, close 281.46 (recalculated)2026-06-21: Fairly valued, close 271.83 (recalculated)2026-07-02: Fairly valued, close 296.51 (recalculated)2026-07-06: Fairly valued, close 298.55 (recalculated)2026-07-09: Fairly valued, close 302.46 (recalculated)2026-07-12: Fairly valued, close 303.44 (recalculated)2026-07-13: Fairly valued, close 306.13 (recalculated)2026-07-14: Fairly valued, close 302.28 (recalculated)2026-07-20: Fairly valued, close 303.99 (recalculated)2026-07-22: Fairly valued, close 300.58 (recalculated)2026-07-25: Fairly valued, close 309.89 (recalculated)2026-07-27: Fairly valued, close 311.15 (recalculated)2026-07-31: Fairly valued, close 311.34 (recalculated)2026-08-03: Fairly valued, close 311.342026-08-07: Fairly valued, close 320.46 (recalculated)2026-08-10: Fairly valued, close 320.462026-08-14: Fairly valued, close 313.82 (recalculated)2026-08-17: Fairly valued, close 313.822643142026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 15.6+0%Fairly valued
2026-06-10P/E 16.0+3%Fairly valued
2026-06-14P/E 16.0+3%Fairly valued
2026-06-16P/E 16.0+3%Fairly valued
2026-06-21P/E 16.0+3%Fairly valued
2026-07-02P/E 16.6+7%Fairly valued
2026-07-06P/E 17.1+10%Fairly valued
2026-07-09P/E 17.1+10%Fairly valued
2026-07-12P/E 17.5+12%Fairly valued
2026-07-13P/E 17.5+12%Fairly valued
2026-07-14P/E 17.5+12%Fairly valued
2026-07-20P/E 17.7+14%Fairly valued
2026-07-22P/E 17.7+14%Fairly valued
2026-07-25P/E 17.8+14%Fairly valued
2026-07-27P/E 17.8+14%Fairly valued
2026-07-31P/E 17.9+15%Fairly valued
2026-08-03P/E 17.8+15%Fairly valued
2026-08-07P/E 18.5+19%Fairly valued
2026-08-10P/E 18.2+17%Fairly valued
2026-08-14P/E 17.6+13%Fairly valued
2026-08-17P/E 17.8+14%Fairly valued
2026-08-21P/E 17.8+15%Fairly valued ← now

Frequently asked questions

Is Cencora stock overvalued?

At a blended P/E of 17.8 versus its historical normal P/E of 15.5, Cencora trades about 15% above its typical valuation, with a PEG of 1.66 on 10.8% forward growth. tickerseer currently rates it fairly valued.

What is Cencora's fair value and PEG?

Cencora trades at a blended P/E of 17.8 against a historical normal P/E of 15.5, a PEG of 1.66, and a forward growth estimate of 10.8%.

Has tickerseer's rating of Cencora changed?

tickerseer's rating has been fairly valued since 2026-06-03.

Industry: Health Care Distributors. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track COR free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.